nodes	percent_of_prediction	percent_of_DWPC	metapath
Histamine Phosphate—SLC22A3—Lamivudine—acquired immunodeficiency syndrome	0.0619	0.0858	CbGbCtD
Histamine Phosphate—SLC22A1—Indinavir—acquired immunodeficiency syndrome	0.0489	0.0677	CbGbCtD
Histamine Phosphate—SLC22A1—Nelfinavir—acquired immunodeficiency syndrome	0.0475	0.0658	CbGbCtD
Histamine Phosphate—SLC22A2—Zidovudine—acquired immunodeficiency syndrome	0.0474	0.0656	CbGbCtD
Histamine Phosphate—SLC22A1—Saquinavir—acquired immunodeficiency syndrome	0.0429	0.0595	CbGbCtD
Histamine Phosphate—SLC22A2—Lamivudine—acquired immunodeficiency syndrome	0.0367	0.0508	CbGbCtD
Histamine Phosphate—SLC22A1—Lamivudine—acquired immunodeficiency syndrome	0.0319	0.0441	CbGbCtD
Histamine Phosphate—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.021	0.0291	CbGbCtD
Histamine Phosphate—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0198	0.0274	CbGbCtD
Histamine Phosphate—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0198	0.0274	CbGbCtD
Histamine Phosphate—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0192	0.0266	CbGbCtD
Histamine Phosphate—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0181	0.0251	CbGbCtD
Histamine Phosphate—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0181	0.0251	CbGbCtD
Histamine Phosphate—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0179	0.0248	CbGbCtD
Histamine Phosphate—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0179	0.0248	CbGbCtD
Histamine Phosphate—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0164	0.0227	CbGbCtD
Histamine Phosphate—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0164	0.0227	CbGbCtD
Histamine Phosphate—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0154	0.0214	CbGbCtD
Histamine Phosphate—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.015	0.0208	CbGbCtD
Histamine Phosphate—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0141	0.0196	CbGbCtD
Histamine Phosphate—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0137	0.019	CbGbCtD
Histamine Phosphate—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0136	0.0188	CbGbCtD
Histamine Phosphate—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0136	0.0188	CbGbCtD
Histamine Phosphate—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.013	0.018	CbGbCtD
Histamine Phosphate—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0124	0.0172	CbGbCtD
Histamine Phosphate—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0124	0.0172	CbGbCtD
Histamine Phosphate—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0122	0.0169	CbGbCtD
Histamine Phosphate—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0115	0.0159	CbGbCtD
Histamine Phosphate—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0115	0.0159	CbGbCtD
Histamine Phosphate—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0104	0.0144	CbGbCtD
Histamine Phosphate—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0104	0.0144	CbGbCtD
Histamine Phosphate—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00898	0.0124	CbGbCtD
Histamine Phosphate—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00872	0.0121	CbGbCtD
Histamine Phosphate—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00788	0.0109	CbGbCtD
Histamine Phosphate—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00788	0.0109	CbGbCtD
Histamine Phosphate—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00756	0.0105	CbGbCtD
Histamine Phosphate—HRH4—blood—acquired immunodeficiency syndrome	0.0025	0.0471	CbGeAlD
Histamine Phosphate—HRH4—bone marrow—acquired immunodeficiency syndrome	0.00241	0.0456	CbGeAlD
Histamine Phosphate—CA4—nerve—acquired immunodeficiency syndrome	0.00207	0.0392	CbGeAlD
Histamine Phosphate—HRH3—digestive system—acquired immunodeficiency syndrome	0.0018	0.034	CbGeAlD
Histamine Phosphate—HRH3—blood—acquired immunodeficiency syndrome	0.00172	0.0324	CbGeAlD
Histamine Phosphate—HNMT—digestive system—acquired immunodeficiency syndrome	0.00142	0.0268	CbGeAlD
Histamine Phosphate—HRH3—nervous system—acquired immunodeficiency syndrome	0.00139	0.0263	CbGeAlD
Histamine Phosphate—HRH2—skin of body—acquired immunodeficiency syndrome	0.00137	0.026	CbGeAlD
Histamine Phosphate—HRH3—central nervous system—acquired immunodeficiency syndrome	0.00134	0.0253	CbGeAlD
Histamine Phosphate—HNMT—vagina—acquired immunodeficiency syndrome	0.00126	0.0237	CbGeAlD
Histamine Phosphate—HNMT—lung—acquired immunodeficiency syndrome	0.00119	0.0224	CbGeAlD
Histamine Phosphate—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.0011	0.0208	CbGeAlD
Histamine Phosphate—HNMT—nervous system—acquired immunodeficiency syndrome	0.0011	0.0208	CbGeAlD
Histamine Phosphate—HRH2—digestive system—acquired immunodeficiency syndrome	0.0011	0.0208	CbGeAlD
Histamine Phosphate—HRH3—brain—acquired immunodeficiency syndrome	0.00107	0.0201	CbGeAlD
Histamine Phosphate—HNMT—central nervous system—acquired immunodeficiency syndrome	0.00106	0.02	CbGeAlD
Histamine Phosphate—HRH2—blood—acquired immunodeficiency syndrome	0.00105	0.0198	CbGeAlD
Histamine Phosphate—SLC22A2—digestive system—acquired immunodeficiency syndrome	0.001	0.0189	CbGeAlD
Histamine Phosphate—HRH2—lung—acquired immunodeficiency syndrome	0.000918	0.0173	CbGeAlD
Histamine Phosphate—HRH2—nervous system—acquired immunodeficiency syndrome	0.00085	0.0161	CbGeAlD
Histamine Phosphate—HNMT—brain—acquired immunodeficiency syndrome	0.00084	0.0159	CbGeAlD
Histamine Phosphate—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000839	0.0158	CbGeAlD
Histamine Phosphate—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000826	0.0156	CbGeAlD
Histamine Phosphate—HRH2—central nervous system—acquired immunodeficiency syndrome	0.000819	0.0155	CbGeAlD
Histamine Phosphate—HNMT—lymph node—acquired immunodeficiency syndrome	0.000812	0.0153	CbGeAlD
Histamine Phosphate—SLC22A5—retina—acquired immunodeficiency syndrome	0.000701	0.0132	CbGeAlD
Histamine Phosphate—SLC22A1—blood—acquired immunodeficiency syndrome	0.000675	0.0127	CbGeAlD
Histamine Phosphate—HRH2—brain—acquired immunodeficiency syndrome	0.00065	0.0123	CbGeAlD
Histamine Phosphate—HRH2—lymph node—acquired immunodeficiency syndrome	0.000628	0.0119	CbGeAlD
Histamine Phosphate—SLC22A1—vagina—acquired immunodeficiency syndrome	0.000625	0.0118	CbGeAlD
Histamine Phosphate—SLC22A5—skin of body—acquired immunodeficiency syndrome	0.000615	0.0116	CbGeAlD
Histamine Phosphate—CA4—digestive system—acquired immunodeficiency syndrome	0.000603	0.0114	CbGeAlD
Histamine Phosphate—SLC22A3—vagina—acquired immunodeficiency syndrome	0.000598	0.0113	CbGeAlD
Histamine Phosphate—CA4—blood—acquired immunodeficiency syndrome	0.000575	0.0109	CbGeAlD
Histamine Phosphate—SLC22A3—lung—acquired immunodeficiency syndrome	0.000565	0.0107	CbGeAlD
Histamine Phosphate—CA4—bone marrow—acquired immunodeficiency syndrome	0.000556	0.0105	CbGeAlD
Histamine Phosphate—CA4—spinal cord—acquired immunodeficiency syndrome	0.000554	0.0105	CbGeAlD
Histamine Phosphate—SLC22A1—nervous system—acquired immunodeficiency syndrome	0.000548	0.0103	CbGeAlD
Histamine Phosphate—SLC22A1—central nervous system—acquired immunodeficiency syndrome	0.000527	0.00996	CbGeAlD
Histamine Phosphate—SLC22A3—nervous system—acquired immunodeficiency syndrome	0.000523	0.00989	CbGeAlD
Histamine Phosphate—SLC22A3—central nervous system—acquired immunodeficiency syndrome	0.000504	0.00952	CbGeAlD
Histamine Phosphate—CA4—lung—acquired immunodeficiency syndrome	0.000504	0.00951	CbGeAlD
Histamine Phosphate—SLC22A5—digestive system—acquired immunodeficiency syndrome	0.000492	0.00929	CbGeAlD
Histamine Phosphate—SLC22A5—blood—acquired immunodeficiency syndrome	0.000469	0.00885	CbGeAlD
Histamine Phosphate—CA4—nervous system—acquired immunodeficiency syndrome	0.000467	0.00881	CbGeAlD
Histamine Phosphate—SLC22A5—spinal cord—acquired immunodeficiency syndrome	0.000452	0.00853	CbGeAlD
Histamine Phosphate—CA4—central nervous system—acquired immunodeficiency syndrome	0.000449	0.00848	CbGeAlD
Histamine Phosphate—SLC22A5—vagina—acquired immunodeficiency syndrome	0.000435	0.00821	CbGeAlD
Histamine Phosphate—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000423	0.00799	CbGeAlD
Histamine Phosphate—SLC22A1—brain—acquired immunodeficiency syndrome	0.000419	0.00791	CbGeAlD
Histamine Phosphate—HRH1—digestive system—acquired immunodeficiency syndrome	0.000417	0.00788	CbGeAlD
Histamine Phosphate—SLC22A5—lung—acquired immunodeficiency syndrome	0.000411	0.00776	CbGeAlD
Histamine Phosphate—CYP2C9—blood—acquired immunodeficiency syndrome	0.000403	0.00761	CbGeAlD
Histamine Phosphate—SLC22A3—brain—acquired immunodeficiency syndrome	0.0004	0.00756	CbGeAlD
Histamine Phosphate—SLC22A3—lymph node—acquired immunodeficiency syndrome	0.000387	0.0073	CbGeAlD
Histamine Phosphate—HRH1—vagina—acquired immunodeficiency syndrome	0.000369	0.00696	CbGeAlD
Histamine Phosphate—CA4—brain—acquired immunodeficiency syndrome	0.000357	0.00673	CbGeAlD
Histamine Phosphate—HRH1—lung—acquired immunodeficiency syndrome	0.000349	0.00658	CbGeAlD
Histamine Phosphate—CA4—lymph node—acquired immunodeficiency syndrome	0.000345	0.00651	CbGeAlD
Histamine Phosphate—HRH1—nervous system—acquired immunodeficiency syndrome	0.000323	0.0061	CbGeAlD
Histamine Phosphate—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000323	0.00609	CbGeAlD
Histamine Phosphate—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000318	0.006	CbGeAlD
Histamine Phosphate—HRH1—central nervous system—acquired immunodeficiency syndrome	0.000311	0.00587	CbGeAlD
Histamine Phosphate—CYP3A4—blood—acquired immunodeficiency syndrome	0.000307	0.00581	CbGeAlD
Histamine Phosphate—CYP2D6—blood—acquired immunodeficiency syndrome	0.000303	0.00571	CbGeAlD
Histamine Phosphate—SLC22A5—brain—acquired immunodeficiency syndrome	0.000291	0.00549	CbGeAlD
Histamine Phosphate—SLC22A5—lymph node—acquired immunodeficiency syndrome	0.000281	0.00531	CbGeAlD
Histamine Phosphate—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.00025	0.00471	CbGeAlD
Histamine Phosphate—HRH1—brain—acquired immunodeficiency syndrome	0.000247	0.00466	CbGeAlD
Histamine Phosphate—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000246	0.00464	CbGeAlD
Histamine Phosphate—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.00024	0.00454	CbGeAlD
Histamine Phosphate—HRH1—lymph node—acquired immunodeficiency syndrome	0.000238	0.0045	CbGeAlD
Histamine Phosphate—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000236	0.00447	CbGeAlD
Histamine Phosphate—HRH4—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000216	0.0162	CbGpPWpGaD
Histamine Phosphate—HRH3—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000197	0.0148	CbGpPWpGaD
Histamine Phosphate—CYP2D6—brain—acquired immunodeficiency syndrome	0.000188	0.00355	CbGeAlD
Histamine Phosphate—HRH3—Monoamine Transport—TNF—acquired immunodeficiency syndrome	0.000185	0.0139	CbGpPWpGaD
Histamine Phosphate—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00018	0.000849	CcSEcCtD
Histamine Phosphate—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000179	0.000848	CcSEcCtD
Histamine Phosphate—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000179	0.000847	CcSEcCtD
Histamine Phosphate—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000179	0.000846	CcSEcCtD
Histamine Phosphate—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000179	0.000845	CcSEcCtD
Histamine Phosphate—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000179	0.000845	CcSEcCtD
Histamine Phosphate—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000179	0.000845	CcSEcCtD
Histamine Phosphate—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000179	0.000845	CcSEcCtD
Histamine Phosphate—HRH3—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000178	0.0134	CbGpPWpGaD
Histamine Phosphate—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000178	0.000842	CcSEcCtD
Histamine Phosphate—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000178	0.000842	CcSEcCtD
Histamine Phosphate—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000178	0.000842	CcSEcCtD
Histamine Phosphate—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000178	0.000839	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000177	0.000836	CcSEcCtD
Histamine Phosphate—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000177	0.000835	CcSEcCtD
Histamine Phosphate—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000177	0.000835	CcSEcCtD
Histamine Phosphate—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000177	0.000835	CcSEcCtD
Histamine Phosphate—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000177	0.000834	CcSEcCtD
Histamine Phosphate—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000176	0.000834	CcSEcCtD
Histamine Phosphate—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000176	0.000833	CcSEcCtD
Histamine Phosphate—Pain—Indinavir—acquired immunodeficiency syndrome	0.000175	0.000828	CcSEcCtD
Histamine Phosphate—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000175	0.000828	CcSEcCtD
Histamine Phosphate—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000175	0.000828	CcSEcCtD
Histamine Phosphate—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000175	0.000827	CcSEcCtD
Histamine Phosphate—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000175	0.000827	CcSEcCtD
Histamine Phosphate—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000175	0.000826	CcSEcCtD
Histamine Phosphate—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000174	0.000824	CcSEcCtD
Histamine Phosphate—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000174	0.000823	CcSEcCtD
Histamine Phosphate—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000174	0.000823	CcSEcCtD
Histamine Phosphate—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000174	0.000822	CcSEcCtD
Histamine Phosphate—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000174	0.000822	CcSEcCtD
Histamine Phosphate—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000174	0.000821	CcSEcCtD
Histamine Phosphate—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000174	0.00082	CcSEcCtD
Histamine Phosphate—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000174	0.00082	CcSEcCtD
Histamine Phosphate—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000173	0.000818	CcSEcCtD
Histamine Phosphate—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000173	0.000818	CcSEcCtD
Histamine Phosphate—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000173	0.000816	CcSEcCtD
Histamine Phosphate—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000173	0.000816	CcSEcCtD
Histamine Phosphate—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000173	0.000815	CcSEcCtD
Histamine Phosphate—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.000813	CcSEcCtD
Histamine Phosphate—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.000813	CcSEcCtD
Histamine Phosphate—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.000813	CcSEcCtD
Histamine Phosphate—HRH4—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000172	0.0129	CbGpPWpGaD
Histamine Phosphate—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.00081	CcSEcCtD
Histamine Phosphate—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000171	0.000808	CcSEcCtD
Histamine Phosphate—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.000807	CcSEcCtD
Histamine Phosphate—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.00017	0.000805	CcSEcCtD
Histamine Phosphate—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.000803	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000169	0.000798	CcSEcCtD
Histamine Phosphate—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000169	0.000798	CcSEcCtD
Histamine Phosphate—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000169	0.000797	CcSEcCtD
Histamine Phosphate—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000168	0.000795	CcSEcCtD
Histamine Phosphate—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000168	0.000795	CcSEcCtD
Histamine Phosphate—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000168	0.000795	CcSEcCtD
Histamine Phosphate—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000168	0.000795	CcSEcCtD
Histamine Phosphate—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000168	0.000794	CcSEcCtD
Histamine Phosphate—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000168	0.000793	CcSEcCtD
Histamine Phosphate—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000168	0.000792	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000168	0.000792	CcSEcCtD
Histamine Phosphate—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000168	0.000792	CcSEcCtD
Histamine Phosphate—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000167	0.00079	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000167	0.00079	CcSEcCtD
Histamine Phosphate—HRH2—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000167	0.0126	CbGpPWpGaD
Histamine Phosphate—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.000789	CcSEcCtD
Histamine Phosphate—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000167	0.000789	CcSEcCtD
Histamine Phosphate—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000167	0.000789	CcSEcCtD
Histamine Phosphate—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000166	0.000786	CcSEcCtD
Histamine Phosphate—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000166	0.000786	CcSEcCtD
Histamine Phosphate—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000166	0.000786	CcSEcCtD
Histamine Phosphate—HRH4—GPCRs, Other—CCR5—acquired immunodeficiency syndrome	0.000166	0.0125	CbGpPWpGaD
Histamine Phosphate—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000166	0.000783	CcSEcCtD
Histamine Phosphate—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000166	0.000782	CcSEcCtD
Histamine Phosphate—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000166	0.000782	CcSEcCtD
Histamine Phosphate—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000166	0.000782	CcSEcCtD
Histamine Phosphate—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000165	0.000782	CcSEcCtD
Histamine Phosphate—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000165	0.000781	CcSEcCtD
Histamine Phosphate—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000165	0.00078	CcSEcCtD
Histamine Phosphate—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000165	0.000777	CcSEcCtD
Histamine Phosphate—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.000775	CcSEcCtD
Histamine Phosphate—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.000775	CcSEcCtD
Histamine Phosphate—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.000775	CcSEcCtD
Histamine Phosphate—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000164	0.000774	CcSEcCtD
Histamine Phosphate—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.000773	CcSEcCtD
Histamine Phosphate—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.000772	CcSEcCtD
Histamine Phosphate—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000163	0.000771	CcSEcCtD
Histamine Phosphate—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.00077	CcSEcCtD
Histamine Phosphate—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000163	0.000769	CcSEcCtD
Histamine Phosphate—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000162	0.000767	CcSEcCtD
Histamine Phosphate—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.000766	CcSEcCtD
Histamine Phosphate—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000162	0.000766	CcSEcCtD
Histamine Phosphate—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000162	0.000766	CcSEcCtD
Histamine Phosphate—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000162	0.000764	CcSEcCtD
Histamine Phosphate—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000162	0.000764	CcSEcCtD
Histamine Phosphate—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000161	0.000763	CcSEcCtD
Histamine Phosphate—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000161	0.000762	CcSEcCtD
Histamine Phosphate—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000161	0.000761	CcSEcCtD
Histamine Phosphate—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000161	0.000758	CcSEcCtD
Histamine Phosphate—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00016	0.000758	CcSEcCtD
Histamine Phosphate—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00016	0.000757	CcSEcCtD
Histamine Phosphate—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.00016	0.000757	CcSEcCtD
Histamine Phosphate—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00016	0.000757	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.00016	0.000756	CcSEcCtD
Histamine Phosphate—Rash—Stavudine—acquired immunodeficiency syndrome	0.00016	0.000755	CcSEcCtD
Histamine Phosphate—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.00016	0.000755	CcSEcCtD
Histamine Phosphate—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00016	0.000755	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.00016	0.000754	CcSEcCtD
Histamine Phosphate—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000159	0.000753	CcSEcCtD
Histamine Phosphate—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000159	0.000753	CcSEcCtD
Histamine Phosphate—Headache—Stavudine—acquired immunodeficiency syndrome	0.000159	0.000751	CcSEcCtD
Histamine Phosphate—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000159	0.00075	CcSEcCtD
Histamine Phosphate—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000159	0.00075	CcSEcCtD
Histamine Phosphate—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000158	0.000749	CcSEcCtD
Histamine Phosphate—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000158	0.000749	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000158	0.000748	CcSEcCtD
Histamine Phosphate—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000158	0.000747	CcSEcCtD
Histamine Phosphate—Rash—Abacavir—acquired immunodeficiency syndrome	0.000158	0.000744	CcSEcCtD
Histamine Phosphate—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000157	0.000744	CcSEcCtD
Histamine Phosphate—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000157	0.000743	CcSEcCtD
Histamine Phosphate—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.000743	CcSEcCtD
Histamine Phosphate—Headache—Abacavir—acquired immunodeficiency syndrome	0.000157	0.000739	CcSEcCtD
Histamine Phosphate—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000156	0.000739	CcSEcCtD
Histamine Phosphate—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000156	0.000738	CcSEcCtD
Histamine Phosphate—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000156	0.000737	CcSEcCtD
Histamine Phosphate—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000156	0.000737	CcSEcCtD
Histamine Phosphate—HRH4—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000155	0.0117	CbGpPWpGaD
Histamine Phosphate—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000155	0.000732	CcSEcCtD
Histamine Phosphate—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000155	0.000731	CcSEcCtD
Histamine Phosphate—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000154	0.000729	CcSEcCtD
Histamine Phosphate—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000154	0.000728	CcSEcCtD
Histamine Phosphate—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000154	0.000728	CcSEcCtD
Histamine Phosphate—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000154	0.000727	CcSEcCtD
Histamine Phosphate—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000154	0.000727	CcSEcCtD
Histamine Phosphate—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000153	0.000723	CcSEcCtD
Histamine Phosphate—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000153	0.000723	CcSEcCtD
Histamine Phosphate—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000153	0.000722	CcSEcCtD
Histamine Phosphate—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.000722	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000153	0.000721	CcSEcCtD
Histamine Phosphate—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000152	0.000719	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000152	0.000716	CcSEcCtD
Histamine Phosphate—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000151	0.000714	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000151	0.000714	CcSEcCtD
Histamine Phosphate—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000151	0.000713	CcSEcCtD
Histamine Phosphate—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000151	0.000713	CcSEcCtD
Histamine Phosphate—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000151	0.000712	CcSEcCtD
Histamine Phosphate—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00015	0.00071	CcSEcCtD
Histamine Phosphate—HRH3—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00015	0.0113	CbGpPWpGaD
Histamine Phosphate—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.000709	CcSEcCtD
Histamine Phosphate—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.000705	CcSEcCtD
Histamine Phosphate—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000149	0.000704	CcSEcCtD
Histamine Phosphate—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000148	0.000701	CcSEcCtD
Histamine Phosphate—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000148	0.0007	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000148	0.000699	CcSEcCtD
Histamine Phosphate—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000148	0.000698	CcSEcCtD
Histamine Phosphate—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000147	0.000696	CcSEcCtD
Histamine Phosphate—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000147	0.000695	CcSEcCtD
Histamine Phosphate—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.000695	CcSEcCtD
Histamine Phosphate—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000147	0.000695	CcSEcCtD
Histamine Phosphate—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.000692	CcSEcCtD
Histamine Phosphate—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.000692	CcSEcCtD
Histamine Phosphate—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000146	0.000692	CcSEcCtD
Histamine Phosphate—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000146	0.000692	CcSEcCtD
Histamine Phosphate—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000146	0.000689	CcSEcCtD
Histamine Phosphate—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000145	0.000686	CcSEcCtD
Histamine Phosphate—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000145	0.000685	CcSEcCtD
Histamine Phosphate—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000143	0.000677	CcSEcCtD
Histamine Phosphate—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000143	0.000677	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000143	0.000674	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.000673	CcSEcCtD
Histamine Phosphate—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.000672	CcSEcCtD
Histamine Phosphate—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.000672	CcSEcCtD
Histamine Phosphate—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000141	0.000668	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000141	0.000667	CcSEcCtD
Histamine Phosphate—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000141	0.000666	CcSEcCtD
Histamine Phosphate—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000141	0.000666	CcSEcCtD
Histamine Phosphate—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.000663	CcSEcCtD
Histamine Phosphate—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00014	0.000663	CcSEcCtD
Histamine Phosphate—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00014	0.000662	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.000662	CcSEcCtD
Histamine Phosphate—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000139	0.000657	CcSEcCtD
Histamine Phosphate—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000139	0.000657	CcSEcCtD
Histamine Phosphate—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000139	0.000656	CcSEcCtD
Histamine Phosphate—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000139	0.000654	CcSEcCtD
Histamine Phosphate—HRH3—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000138	0.0104	CbGpPWpGaD
Histamine Phosphate—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000138	0.000652	CcSEcCtD
Histamine Phosphate—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000137	0.000647	CcSEcCtD
Histamine Phosphate—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000137	0.000646	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000137	0.000645	CcSEcCtD
Histamine Phosphate—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000136	0.000643	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000642	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.000642	CcSEcCtD
Histamine Phosphate—HRH3—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000136	0.0102	CbGpPWpGaD
Histamine Phosphate—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.000641	CcSEcCtD
Histamine Phosphate—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000136	0.00064	CcSEcCtD
Histamine Phosphate—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.00064	CcSEcCtD
Histamine Phosphate—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.00064	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.000637	CcSEcCtD
Histamine Phosphate—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.000636	CcSEcCtD
Histamine Phosphate—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.000636	CcSEcCtD
Histamine Phosphate—HRH2—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000133	0.01	CbGpPWpGaD
Histamine Phosphate—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000133	0.000628	CcSEcCtD
Histamine Phosphate—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000133	0.000626	CcSEcCtD
Histamine Phosphate—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000131	0.000619	CcSEcCtD
Histamine Phosphate—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000131	0.000619	CcSEcCtD
Histamine Phosphate—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000131	0.000619	CcSEcCtD
Histamine Phosphate—HRH4—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000131	0.00982	CbGpPWpGaD
Histamine Phosphate—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.000616	CcSEcCtD
Histamine Phosphate—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.000616	CcSEcCtD
Histamine Phosphate—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00013	0.000616	CcSEcCtD
Histamine Phosphate—HRH3—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.00013	0.00979	CbGpPWpGaD
Histamine Phosphate—HRH3—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.00013	0.00979	CbGpPWpGaD
Histamine Phosphate—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000613	CcSEcCtD
Histamine Phosphate—Rash—Indinavir—acquired immunodeficiency syndrome	0.000129	0.000611	CcSEcCtD
Histamine Phosphate—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000129	0.00061	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.000608	CcSEcCtD
Histamine Phosphate—HRH3—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000129	0.00966	CbGpPWpGaD
Histamine Phosphate—Headache—Indinavir—acquired immunodeficiency syndrome	0.000128	0.000607	CcSEcCtD
Histamine Phosphate—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000128	0.000605	CcSEcCtD
Histamine Phosphate—HRH3—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000127	0.00956	CbGpPWpGaD
Histamine Phosphate—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000127	0.000599	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.000596	CcSEcCtD
Histamine Phosphate—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.000591	CcSEcCtD
Histamine Phosphate—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.000588	CcSEcCtD
Histamine Phosphate—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.000588	CcSEcCtD
Histamine Phosphate—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000123	0.000582	CcSEcCtD
Histamine Phosphate—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000123	0.000581	CcSEcCtD
Histamine Phosphate—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000123	0.000579	CcSEcCtD
Histamine Phosphate—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000122	0.000577	CcSEcCtD
Histamine Phosphate—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000122	0.000576	CcSEcCtD
Histamine Phosphate—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000122	0.000575	CcSEcCtD
Histamine Phosphate—HRH3—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000122	0.00915	CbGpPWpGaD
Histamine Phosphate—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000574	CcSEcCtD
Histamine Phosphate—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000121	0.000573	CcSEcCtD
Histamine Phosphate—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.000573	CcSEcCtD
Histamine Phosphate—HRH3—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000121	0.00909	CbGpPWpGaD
Histamine Phosphate—HRH4—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000121	0.00906	CbGpPWpGaD
Histamine Phosphate—HRH2—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00012	0.00905	CbGpPWpGaD
Histamine Phosphate—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000559	CcSEcCtD
Histamine Phosphate—HRH4—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000118	0.00888	CbGpPWpGaD
Histamine Phosphate—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000118	0.000557	CcSEcCtD
Histamine Phosphate—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000554	CcSEcCtD
Histamine Phosphate—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000117	0.000552	CcSEcCtD
Histamine Phosphate—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000117	0.000551	CcSEcCtD
Histamine Phosphate—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.000551	CcSEcCtD
Histamine Phosphate—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.000548	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000548	CcSEcCtD
Histamine Phosphate—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000115	0.000544	CcSEcCtD
Histamine Phosphate—HRH4—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000113	0.00852	CbGpPWpGaD
Histamine Phosphate—HRH4—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000113	0.00852	CbGpPWpGaD
Histamine Phosphate—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000535	CcSEcCtD
Histamine Phosphate—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.000533	CcSEcCtD
Histamine Phosphate—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000533	CcSEcCtD
Histamine Phosphate—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000526	CcSEcCtD
Histamine Phosphate—HRH4—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000111	0.00832	CbGpPWpGaD
Histamine Phosphate—HRH3—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00011	0.00828	CbGpPWpGaD
Histamine Phosphate—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00011	0.00052	CcSEcCtD
Histamine Phosphate—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.000515	CcSEcCtD
Histamine Phosphate—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000109	0.000515	CcSEcCtD
Histamine Phosphate—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.00051	CcSEcCtD
Histamine Phosphate—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.00051	CcSEcCtD
Histamine Phosphate—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000509	CcSEcCtD
Histamine Phosphate—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000107	0.00808	CbGpPWpGaD
Histamine Phosphate—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.000507	CcSEcCtD
Histamine Phosphate—HRH4—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000106	0.00797	CbGpPWpGaD
Histamine Phosphate—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.000495	CcSEcCtD
Histamine Phosphate—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000492	CcSEcCtD
Histamine Phosphate—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000491	CcSEcCtD
Histamine Phosphate—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000491	CcSEcCtD
Histamine Phosphate—HRH3—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000104	0.00778	CbGpPWpGaD
Histamine Phosphate—HRH3—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000104	0.00778	CbGpPWpGaD
Histamine Phosphate—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000488	CcSEcCtD
Histamine Phosphate—HRH1—IL-4 Signaling Pathway—IL4—acquired immunodeficiency syndrome	0.000103	0.00773	CbGpPWpGaD
Histamine Phosphate—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.000481	CcSEcCtD
Histamine Phosphate—HRH2—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000101	0.00762	CbGpPWpGaD
Histamine Phosphate—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.0001	0.000473	CcSEcCtD
Histamine Phosphate—Rash—Lamivudine—acquired immunodeficiency syndrome	9.92e-05	0.000469	CcSEcCtD
Histamine Phosphate—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	9.91e-05	0.000468	CcSEcCtD
Histamine Phosphate—HRH3—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	9.9e-05	0.00745	CbGpPWpGaD
Histamine Phosphate—Headache—Lamivudine—acquired immunodeficiency syndrome	9.86e-05	0.000466	CcSEcCtD
Histamine Phosphate—Nausea—Saquinavir—acquired immunodeficiency syndrome	9.8e-05	0.000463	CcSEcCtD
Histamine Phosphate—HRH4—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	9.58e-05	0.00721	CbGpPWpGaD
Histamine Phosphate—Nausea—Lamivudine—acquired immunodeficiency syndrome	9.35e-05	0.000442	CcSEcCtD
Histamine Phosphate—HRH3—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	9.27e-05	0.00697	CbGpPWpGaD
Histamine Phosphate—HRH2—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	9.16e-05	0.00689	CbGpPWpGaD
Histamine Phosphate—HRH4—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	9.01e-05	0.00678	CbGpPWpGaD
Histamine Phosphate—HRH4—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	9.01e-05	0.00678	CbGpPWpGaD
Histamine Phosphate—HRH3—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	8.92e-05	0.00671	CbGpPWpGaD
Histamine Phosphate—HRH2—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	8.67e-05	0.00652	CbGpPWpGaD
Histamine Phosphate—HRH4—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	8.62e-05	0.00648	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	8.58e-05	0.00645	CbGpPWpGaD
Histamine Phosphate—HRH3—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	8.38e-05	0.0063	CbGpPWpGaD
Histamine Phosphate—HRH3—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	8.28e-05	0.00623	CbGpPWpGaD
Histamine Phosphate—HRH2—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	8.22e-05	0.00618	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	8.18e-05	0.00615	CbGpPWpGaD
Histamine Phosphate—HRH2—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	8.16e-05	0.00613	CbGpPWpGaD
Histamine Phosphate—HRH4—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	8.07e-05	0.00607	CbGpPWpGaD
Histamine Phosphate—HRH3—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	7.88e-05	0.00593	CbGpPWpGaD
Histamine Phosphate—HRH3—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	7.88e-05	0.00593	CbGpPWpGaD
Histamine Phosphate—HRH3—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	7.87e-05	0.00592	CbGpPWpGaD
Histamine Phosphate—HRH4—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	7.77e-05	0.00584	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	7.7e-05	0.00579	CbGpPWpGaD
Histamine Phosphate—CA4—Metabolism—TAT—acquired immunodeficiency syndrome	7.55e-05	0.00568	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	7.51e-05	0.00565	CbGpPWpGaD
Histamine Phosphate—HRH2—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	7.43e-05	0.00559	CbGpPWpGaD
Histamine Phosphate—HRH4—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	7.3e-05	0.00549	CbGpPWpGaD
Histamine Phosphate—HRH3—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	7.09e-05	0.00534	CbGpPWpGaD
Histamine Phosphate—HRH2—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	6.99e-05	0.00525	CbGpPWpGaD
Histamine Phosphate—HRH2—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	6.99e-05	0.00525	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	6.96e-05	0.00524	CbGpPWpGaD
Histamine Phosphate—HRH4—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	6.86e-05	0.00516	CbGpPWpGaD
Histamine Phosphate—HRH4—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	6.86e-05	0.00516	CbGpPWpGaD
Histamine Phosphate—HRH4—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	6.86e-05	0.00516	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	6.7e-05	0.00504	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	6.54e-05	0.00492	CbGpPWpGaD
Histamine Phosphate—HRH1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	6.51e-05	0.0049	CbGpPWpGaD
Histamine Phosphate—CA4—Metabolism—AGPS—acquired immunodeficiency syndrome	6.42e-05	0.00483	CbGpPWpGaD
Histamine Phosphate—HRH2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	6.26e-05	0.00471	CbGpPWpGaD
Histamine Phosphate—HRH4—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	6.18e-05	0.00464	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	6.06e-05	0.00456	CbGpPWpGaD
Histamine Phosphate—HRH3—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	6e-05	0.00451	CbGpPWpGaD
Histamine Phosphate—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	5.89e-05	0.00443	CbGpPWpGaD
Histamine Phosphate—HRH2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	5.66e-05	0.00426	CbGpPWpGaD
Histamine Phosphate—HRH2—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	5.59e-05	0.0042	CbGpPWpGaD
Histamine Phosphate—HRH3—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	5.4e-05	0.00406	CbGpPWpGaD
Histamine Phosphate—HRH2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	5.32e-05	0.004	CbGpPWpGaD
Histamine Phosphate—HRH2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	5.32e-05	0.004	CbGpPWpGaD
Histamine Phosphate—HRH2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	5.32e-05	0.004	CbGpPWpGaD
Histamine Phosphate—HRH4—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	5.22e-05	0.00393	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	5.2e-05	0.00391	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	5.07e-05	0.00381	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	4.96e-05	0.00373	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—TAT—acquired immunodeficiency syndrome	4.86e-05	0.00366	CbGpPWpGaD
Histamine Phosphate—HRH2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	4.79e-05	0.0036	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	4.76e-05	0.00358	CbGpPWpGaD
Histamine Phosphate—HRH3—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	4.74e-05	0.00356	CbGpPWpGaD
Histamine Phosphate—HRH4—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	4.7e-05	0.00354	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	4.7e-05	0.00354	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	4.55e-05	0.00342	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	4.55e-05	0.00342	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	4.48e-05	0.00337	CbGpPWpGaD
Histamine Phosphate—HRH3—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	4.45e-05	0.00335	CbGpPWpGaD
Histamine Phosphate—HRH3—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	4.45e-05	0.00335	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	4.3e-05	0.00324	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	4.25e-05	0.00319	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	4.2e-05	0.00316	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	4.14e-05	0.00311	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—AGPS—acquired immunodeficiency syndrome	4.14e-05	0.00311	CbGpPWpGaD
Histamine Phosphate—HRH4—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	4.12e-05	0.0031	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.11e-05	0.00309	CbGpPWpGaD
Histamine Phosphate—HRH2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	4.05e-05	0.00304	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	4.05e-05	0.00304	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	4.05e-05	0.00304	CbGpPWpGaD
Histamine Phosphate—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	4.02e-05	0.00302	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	3.99e-05	0.003	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	3.96e-05	0.00298	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	3.96e-05	0.00298	CbGpPWpGaD
Histamine Phosphate—HRH4—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	3.88e-05	0.00292	CbGpPWpGaD
Histamine Phosphate—HRH4—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	3.88e-05	0.00292	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	3.75e-05	0.00282	CbGpPWpGaD
Histamine Phosphate—HRH2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	3.65e-05	0.00274	CbGpPWpGaD
Histamine Phosphate—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	3.64e-05	0.00274	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.58e-05	0.00269	CbGpPWpGaD
Histamine Phosphate—SLC22A3—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	3.56e-05	0.00268	CbGpPWpGaD
Histamine Phosphate—SLC22A5—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	3.55e-05	0.00267	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	3.52e-05	0.00265	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	3.52e-05	0.00265	CbGpPWpGaD
Histamine Phosphate—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	3.42e-05	0.00257	CbGpPWpGaD
Histamine Phosphate—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	3.42e-05	0.00257	CbGpPWpGaD
Histamine Phosphate—HRH3—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.39e-05	0.00255	CbGpPWpGaD
Histamine Phosphate—HRH3—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.34e-05	0.00251	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	3.21e-05	0.00241	CbGpPWpGaD
Histamine Phosphate—HRH2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	3.2e-05	0.0024	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.08e-05	0.00231	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	3.07e-05	0.00231	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	3.07e-05	0.00231	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	3.06e-05	0.0023	CbGpPWpGaD
Histamine Phosphate—HRH3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.05e-05	0.0023	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—TAT—acquired immunodeficiency syndrome	3.05e-05	0.00229	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.03e-05	0.00228	CbGpPWpGaD
Histamine Phosphate—HRH2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	3.01e-05	0.00226	CbGpPWpGaD
Histamine Phosphate—HRH2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	3.01e-05	0.00226	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	2.97e-05	0.00224	CbGpPWpGaD
Histamine Phosphate—HRH4—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.95e-05	0.00222	CbGpPWpGaD
Histamine Phosphate—HRH4—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.91e-05	0.00219	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.9e-05	0.00218	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—TAT—acquired immunodeficiency syndrome	2.84e-05	0.00214	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.81e-05	0.00211	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.78e-05	0.00209	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.77e-05	0.00208	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	2.77e-05	0.00208	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	2.74e-05	0.00206	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.73e-05	0.00205	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.73e-05	0.00205	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.68e-05	0.00201	CbGpPWpGaD
Histamine Phosphate—HRH4—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.66e-05	0.002	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.64e-05	0.00198	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	2.6e-05	0.00196	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	2.6e-05	0.00196	CbGpPWpGaD
Histamine Phosphate—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	2.6e-05	0.00196	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—AGPS—acquired immunodeficiency syndrome	2.59e-05	0.00195	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	2.54e-05	0.00191	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.54e-05	0.00191	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	2.48e-05	0.00187	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.45e-05	0.00184	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.42e-05	0.00182	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.41e-05	0.00182	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.39e-05	0.0018	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.39e-05	0.0018	CbGpPWpGaD
Histamine Phosphate—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	2.34e-05	0.00176	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	2.3e-05	0.00173	CbGpPWpGaD
Histamine Phosphate—HRH2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.29e-05	0.00172	CbGpPWpGaD
Histamine Phosphate—HRH2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.25e-05	0.00169	CbGpPWpGaD
Histamine Phosphate—SLC22A2—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.24e-05	0.00168	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.21e-05	0.00166	CbGpPWpGaD
Histamine Phosphate—SLC22A1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.08e-05	0.00157	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.08e-05	0.00156	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.08e-05	0.00156	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.08e-05	0.00156	CbGpPWpGaD
Histamine Phosphate—HRH2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.06e-05	0.00155	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.05e-05	0.00154	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	1.98e-05	0.00149	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.9e-05	0.00143	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.87e-05	0.00141	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.82e-05	0.00137	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.81e-05	0.00136	CbGpPWpGaD
Histamine Phosphate—SLC22A5—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.81e-05	0.00136	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.79e-05	0.00135	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	1.78e-05	0.00134	CbGpPWpGaD
Histamine Phosphate—HRH3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.76e-05	0.00133	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.72e-05	0.00129	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.64e-05	0.00123	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.61e-05	0.00121	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.61e-05	0.00121	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.6e-05	0.0012	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.58e-05	0.00119	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	1.57e-05	0.00118	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	1.57e-05	0.00118	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	1.57e-05	0.00118	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.56e-05	0.00117	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	1.56e-05	0.00117	CbGpPWpGaD
Histamine Phosphate—HRH4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.54e-05	0.00115	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.5e-05	0.00113	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.5e-05	0.00113	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.47e-05	0.00111	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.47e-05	0.00111	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.43e-05	0.00107	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.42e-05	0.00107	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.39e-05	0.00105	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.36e-05	0.00102	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.34e-05	0.001	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.34e-05	0.001	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	1.34e-05	0.001	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	1.32e-05	0.000996	CbGpPWpGaD
Histamine Phosphate—CA4—Metabolism—ALB—acquired immunodeficiency syndrome	1.32e-05	0.00099	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.23e-05	0.000923	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.21e-05	0.000909	CbGpPWpGaD
Histamine Phosphate—HRH2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.19e-05	0.000895	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.14e-05	0.000854	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.12e-05	0.000842	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.11e-05	0.000831	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.1e-05	0.000829	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.08e-05	0.000813	CbGpPWpGaD
Histamine Phosphate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.07e-05	0.000808	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.06e-05	0.000796	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	1.03e-05	0.000772	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.02e-05	0.000765	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.01e-05	0.000758	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1e-05	0.000753	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.46e-06	0.000712	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.42e-06	0.000708	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	9.28e-06	0.000698	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	9.16e-06	0.000689	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	8.73e-06	0.000657	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—ALB—acquired immunodeficiency syndrome	8.48e-06	0.000638	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	8.4e-06	0.000631	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.24e-06	0.00062	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.2e-06	0.000616	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	7.89e-06	0.000594	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	7.89e-06	0.000594	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.39e-06	0.00048	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.36e-06	0.000478	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	6.1e-06	0.000459	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.01e-06	0.000452	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.92e-06	0.000445	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.83e-06	0.000438	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.56e-06	0.000418	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.41e-06	0.000407	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—ALB—acquired immunodeficiency syndrome	5.32e-06	0.0004	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.29e-06	0.000398	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—ALB—acquired immunodeficiency syndrome	4.96e-06	0.000373	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.84e-06	0.000364	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.75e-06	0.000282	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.13e-06	0.000235	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.11e-06	0.000234	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	2.74e-06	0.000206	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	2.72e-06	0.000204	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.84e-06	0.000138	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	1.79e-06	0.000135	CbGpPWpGaD
